Skip to content

Home
Insights
Brochures
Careers
About us
News

Home
Insights
Brochures
Careers
About us
News

Pharma News

Highlights from the week of 22nd June - 29th June Gilead Sciences ( FDA, EU, Approval ) FDA and EC grant approval to Gilead's TRODELVY for the treatment of adults with unresectable, locally advanced, mTNBC Merck ( FDA, Approval ) FDA approves Merck's KEYTRUDA and KEYTRUDA QLEX, each in combination with TRODELVY, for the first-line treatment of adults with unresectable, locally advanced, or metastatic TNBC AbbVie ( EU, Approval ) AbbVie's MAVIRET obtains EC approval to treat acute HCV infection in those aged 3 years and older AstraZeneca ( EU, Approval ) EC provides approval to AstraZeneca and Daiichi Sankyo's ENHERTU as monotherapy to treat adults with unresectable or metastatic HER2-positive IHC3+ solid tumours All logos and trademarks remain the intellectual properties of their respective owners

Highlights from the Week of 22nd June – 29th June in the world of pharma and healthcare!

June 29, 2026

Highlights from the Week of 15th June 2026 - 22nd June 2026 ( FDA, Approval ) Merck's CAPVAXIVE gets FDA approval for an expanded indication that includes those aged 12-17 years with an increased pneumococcal disease risk ( FDA, Approval ) AbbVie's Allergan Aesthetics receives FDA approval for SKINVIVE by JUVÉDERM to reduce neck lines in adults over the age of 21 ( FDA, Approval ) FDA approves GSK and Spero Therapeutics' UTEBZI for the treatment of cUTIs, including pyelonephritis, in adults with limited or no alternative oral options ( EU, Approval ) EC gives centralized marketing authorization to CinnaGen's ZANDORIAH, a biosimilar for the treatment of osteoporosis in adults Pg 1/3 All logos and trademarks remain the intellectual properties of their respective owners

Highlights from the Week of 15th June – 22nd June in the world of pharma and healthcare!

June 22, 2026

Highlights from the week of 08th June - 15th June Sanofi ( FDA, Approval ) Sanofi's Tzield gets FDA approval to treat patients recently diagnosed with Stage 3 type 1 diabetes Eli Lilly ( FDA, Approval ) FDA grants approval to Eli Lilly's EBGLYSS 250 mg/2 mL SC injection for maintenance dosing to treat moderate-to-severe atopic dermatitis AstraZeneca ( FDA, Approval ) AstraZeneca's TRUQAP, in combination with abiraterone and prednisone, gains FDA approval to treat adults with mAPMN/S prostate cancer Novo Nordisk ( UK, Approval ) MHRA grants approval to Novo Nordisk's WEGOVY as an injectable treatment adjunct to a reduced-calorie diet and increased physical activity for obesity All logos and trademarks remain the intellectual properties of their respective owners

Highlights from the Week of 08th June – 15th June in the world of pharma and healthcare!

June 15, 2026

« Previous Page1 Page2 Page3 Page4 Page5 Next »

Investor calendar

2026 RBC Capital Markets Global Healthcare Conference 2026 RBC Capital Markets Global Healthcare Conference May 19,2026 To May 20,2026 May 20 May 19 All logos and trademarks remain the intellectual properties of their respective owners

Attention stay up to date with the latest investor calls by checking out our calendar for the week of May 19,2026 To May 20,2026

May 18, 2026

Bank of America Securities Healthcare Conference May 12,2026 To May 14,2026 May 12 May 13 May 14 All logos and trademarks remain the intellectual properties of their respective owners

Attention stay up to date with the latest investor calls by checking out our calendar for the week of May 12,2026 To May 14,2026

May 11, 2026

Q1 2026 Earning Conference Call May 04,2026 To May 07,2026 May 04 May 05 May 07 All logos and trademarks remain the intellectual properties of their respective owners

Attention stay up to date with the latest investor calls by checking out our calendar for the week of May 04,2026 To May 07,2026

May 5, 2026

« Previous Page1 Page2 Page3 Page4 Page5 Next »

Healthcare Insights

INFLAMMATORY BOWEL DISE SE IBD is an umbrella term for a group of conditions that cause swelling and inflammation of the tissues in the digestive tract Global Prevalence and Incidence Country-wise affected population Prevalence 2.4-3.1M 229.7 per 100,000 2.5-3 M Incidence Low Low with increase 0.18 M High TYPES OF IBD Crohn's disease Ulcerative colitis Crohn's disease (CD): It can affect any part of the digestive tract from mouth to anus and causes deep, tissue-layer inflammation Ulcerative colitis (UC): It affects only the colon and rectum's inner lining, causing inflammation and ulcers DIAGNOSIS Blood Test Stool Test Upper Endoscopy Colonoscopy Tissue Biopsy Imaging Studies Risk factors Causes of inflammatory Bowel Disease Medium Women face a higher risk of CD; men face a higher risk of UC Smoking affects development and severity of Crohn's Commonly diagnosed between ages 15-35 Luminal Factors Microbiome Intestinal Immune System Alterations Environmental Factor Genetic Predisposition SYMPTOMS Loss of appetite Fatigue Stomach aches and cramps Weight loss Diarrhea Blood in your stool TREATMENT Surgery Bowel resection Top-down approach Nutritional support Probiotics Biologic therapy Adalimumab & Infliximab Immunosuppressants Methotrexate, Azathioprine & Mercaptopurine Corticosteroids Budesonide, Methylprednisolone & Prednisolone 5-ASA | Antibiotics 5 ASA- Mesalamine & Sulfasalazine | Antibiotics- Ciprofloxacin & Metronidazole Step-up approach Vyuhpharma® All Rights Reserved Note: This report is generated based on publicly available data

True workplace inclusivity means supporting employees with chronic, often invisible conditions. Inflammatory Bowel Disease (IBD) affects millions of professionals worldwide, impacting daily life, energy and productivity.This World IBD Day, let’s advocate for understanding, flexible workplaces, and healthcare support. 💼💜

May 19, 2026

High blood pressure isn’t just a clinical issue; it’s a productivity and workplace wellness issue. Given that stress is a major contributor to hypertension, the 2026 theme “Controlling Hypertension Together” hits home for leadership teams everywhere. Let’s foster environments where health is as important as the bottom line. 📈❤️

May 17, 2026

On World Lupus Day, we stand in support of everyone affected by lupus — raising awareness, encouraging early diagnosis, and advocating for better care and research. 💜Together, we can help improve lives through awareness, innovation, and compassion.

May 10, 2026

« Previous Page1 Page2 Page3 Page4 Page5 Next »

The Pharma BI division of

Vyuhgenics Inc.

Henderson, Nevada, USA – 89014

Vyuhpharma ®, All Rights Reserved.

Sitemap

Terms of use

Connect with us

Please fill in the information below, and we'll get back to you.

Full Name

Email Address

Your Company

Contact

Your message